Canadian Solar Inc. (NASDAQ:CSIQ) has announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., has entered into an Engineering, Procurement and Construction (EPC) contract with Kinston Solar LP for the construction of 140 MW solar PV farm located in Ontario, Canada. This considered to be the largest EPC agreement ever signed by Canadian Solar. Canadian Solar Inc. (NASDAQ:CSIQ) net profit margin is 2.10% and weekly performance is -0.20%. On last trading day company shares ended up $29.73. Analysts mean target price for the company is $42.13. Canadian Solar Inc. (NASDAQ:CSIQ) distance from 50-day simple moving average is 11.55%.
Genetic Technologies Limited (NASDAQ:GENE), a Melbourne, Australia-based genetics testing company announced in a press release that it had received 1,096 patient samples for its BREVAGen breast cancer test in its latest quarter ended June 30. The company noted that the test samples received had increased 37% over the previous quarter ended in March, and reached a level seen in the last quarter of calendar year 2013. Genetic Technologies Limited (ADR) (NASDAQ:GENE) shares advanced 11.28% in last trading session and ended the day on $1.14. Genetic Technologies Limited (ADR) (NASDAQ:GENE) quarterly performance is -20.83%.
On June 16,2014 DARA BioSciences (NASDAQ:DARA)‘s stock had its “neutral” rating restated by Zacks in a research note issued on Monday. They currently have a $1.75 price target on the stock.DARA Biosciences Inc (NASDAQ:DARA) shares moved up 4.92% in last trading session and was closed at $1.28, while trading in range of $1.22-$1.33. DARA Biosciences Inc (NASDAQ:DARA) year to date performance is -52.59%.
Agenus Inc (NASDAQ:AGEN) has a Zacks Rank #2 (Buy). Agenus Inc (NASDAQ:AGEN) ended the last trading day at $3.62. Company weekly volatility is calculated as 9.42% and price to cash ratio as 3.06. Agenus Inc (NASDAQ:AGEN) showed a positive weekly performance of 6.47%.